Neuromyelitis optica with onset in childhood and adolescence

Pediatric Neurology

Volumn 50, Issue 1, 2014, Pages 66-68

  Fragoso, Yara Dadalti ^a   Ferreira, Maria L B ^b   Oliveira, Enedina M L ^c   Domingues, Renan B ^d   Ribeiro, Taysa A G J ^e   Brooks, Joseph B B ^a   Claudino, Rinaldo ^f   Netto, Jussara M K ^g   Gomes, Sidney ^h   Adoni, Tarso ⁱ   Carneiro, Denise S D ^e   Fonseca, Daiana R P ^b   Fragomeni, Manuela O ^c   Oliveira, Francisco T M ^h   Oliveira, Celso L S ^a   Saldanha, Patricia C O ^d   Souza, Jorge M B ^f  

^a UNIVERSIDADE METROPOLITANA DE SANTOS   (Brazil)

^b HOSPITAL DA RESTAURAÇÃO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Centro de Ciencias da Saude   (Brazil)

^e FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^f FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^g FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

ⁱ HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

adolescents; children; demyelinating diseases; Devic; multiple sclerosis; neuromyelitis optica

Indexed keywords

AZATHIOPRINE; GLATIRAMER; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONSULTATION; DISEASE DURATION; EXPANDED DISABILITY SCALE SCORE; FEMALE; HUMAN; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIST; ONSET AGE; PATIENT CARE; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; SCORING SYSTEM; YOUNG ADULT; NEUROMYELITIS OPTICA; PATHOPHYSIOLOGY;

ADOLESCENT; AGE OF ONSET; CHILD; FEMALE; HUMANS; MALE; NEUROMYELITIS OPTICA;

EID: 84891625713     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2013.07.003     Document Type: Article

References (12)

1. M.A. Mealy, D.M. Wingerchuk, B.M. Greenberg, and M. Levy Epidemiology of neuromyelitis optica in the United States: a multicenter analysis Arch Neurol 69 2012 1176 1180
2. J.M. Tillema, and A. McKeon The spectrum of neuromyelitis optica (NMO) in childhood J Child Neurol 27 2012 1437 1447
3. L.B. Krupp, B. Banwell, and S. Tenembaum Consensus definitions proposed for pediatric multiple sclerosis and related disorders Neurology 68 16, Suppl 2 2007 S7 S12
4. D.M. Wingerchuk, V.A. Lennon, S.J. Pittock, C.F. Lucchinetti, and B.G. Weinshenker Revised diagnostic criteria for neuromyelitis optica Neurology 66 2006 1485 1489
5. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology (Cleveland) 33 1983 1444 1452
6. S. Bigi, and B. Banwell Pediatric multiple sclerosis J Child Neurol 27 2012 1378 1383
7. N. Collongues, R. Marignier, and H. Zéphir et al. Long-term follow-up of neuromyelitis optica with a pediatric onset Neurology 75 2010 1084 1088
8. T.E. Lotze, J.L. Northrop, G.J. Hutton, B. Ross, J.S. Schiffman, and J.V. Hunter Spectrum of pediatric neuromyelitis optica Pediatrics 122 2008 1039 1047
9. A. McKeon, V.A. Lennon, and T. Lotze et al. CNS aquaporin-4 autoimmunity in children Neurology 71 2008 93 100
10. J.A. Peña, M.E. Ravelo, E. Mora-La Cruz, and C. Montiel-Nava NMO in pediatric patients: brain involvement and clinical expression Arq Neuropsiquiatr 69 2011 34 38
11. E.A. Yeh, J.B. Parrish, and B. Weinstock-Guttman Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes Expert Rev Neurother 11 2011 433 440
12. S.H. Kim, W. Kim, X.F. Li, I.J. Jung, and H.J. Kim Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder? Mult Scler 18 2012 1480 1483